Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Cancers|July 2, 2021
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter StudyNicolas Williet, Angelica Petrillo, Gaël Roth, et al.
Inflammatory Bowel Diseases|May 2, 2015
Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative ColitisSylvie Pillet, Camille Jarlot, Mathilde Courault, et al.
Inflammatory Bowel Diseases|August 18, 2021
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug LevelsXavier Roblin, Capucine Genin, Stéphane Nancey, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 15, 2015
Metals distribution in colorectal biopsies: New insight on the elemental fingerprint of tumour tissueLeslie Rinaldi, Gabriele Barabino, Jean-Philippe Klein, et al.
Alimentary Pharmacology & Therapeutics|April 19, 2021
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel diseaseQuentin Tournier, Stephane Paul, Nicolas Williet, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trialsJulien Edeline, John Bridgewater, Boris Campillo-Gimenez, et al.
Oncotarget|February 4, 2017
The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarkerNicolas Williet, Carmen Adina Petcu, Leslie Rinaldi, et al.
Inflammatory Bowel Diseases|December 22, 2016
Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's DiseaseXavier Roblin, Gerard Duru, Nicolas Williet, et al.
Gut|January 26, 2020
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trialXavier Roblin, Nicolas Williet, Gilles Boschetti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2023
Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trialDelphine Salfati, Margaux Huot, Thomas Aparicio, et al.
Pageof 10